SE0100195D0 - Evaluation procedures for anti-tumor activity - Google Patents

Evaluation procedures for anti-tumor activity

Info

Publication number
SE0100195D0
SE0100195D0 SE0100195A SE0100195A SE0100195D0 SE 0100195 D0 SE0100195 D0 SE 0100195D0 SE 0100195 A SE0100195 A SE 0100195A SE 0100195 A SE0100195 A SE 0100195A SE 0100195 D0 SE0100195 D0 SE 0100195D0
Authority
SE
Sweden
Prior art keywords
tumor activity
evaluation procedures
koji
glucan
fermenting
Prior art date
Application number
SE0100195A
Other languages
Swedish (sv)
Other versions
SE0100195L (en
Inventor
Kozo Niwa
Original Assignee
Kozo Niwa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kozo Niwa filed Critical Kozo Niwa
Publication of SE0100195L publication Critical patent/SE0100195L/en
Publication of SE0100195D0 publication Critical patent/SE0100195D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material

Abstract

A method for strengthening an antitumor activity by roasting a polysaccharide or mushroom containing b -glucan by far infrared rays, then, fermenting by adding "Koji", and further making an oily agent. Also claimed is a method of evaluating the efficacy of the drug by an in vitro method based on lipid peroxidation.
SE0100195A 1998-09-17 2001-01-24 Evaluation procedures for anti-tumor activity SE0100195D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26375398 1998-09-17
JP10323374A JP2000159682A (en) 1998-09-17 1998-11-13 Method of strengthening antitumor activity of crude drug, composition containing crude drug for strengthening antitumor activity, method of evaluating antitumor effectivity treated by crude drug and method of evaluating antitumor effectivity of crud drug

Publications (2)

Publication Number Publication Date
SE0100195L SE0100195L (en) 2001-01-24
SE0100195D0 true SE0100195D0 (en) 2001-01-24

Family

ID=26546176

Family Applications (2)

Application Number Title Priority Date Filing Date
SE9903307A SE9903307L (en) 1998-09-17 1999-09-16 Amplification of antitumor activity of natural drugs from fungi
SE0100195A SE0100195D0 (en) 1998-09-17 2001-01-24 Evaluation procedures for anti-tumor activity

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE9903307A SE9903307L (en) 1998-09-17 1999-09-16 Amplification of antitumor activity of natural drugs from fungi

Country Status (19)

Country Link
JP (1) JP2000159682A (en)
KR (1) KR20000023206A (en)
CN (1) CN1255376A (en)
AU (1) AU4486299A (en)
BE (1) BE1012725A5 (en)
CA (1) CA2282234A1 (en)
DE (1) DE19944695A1 (en)
DK (1) DK199901235A (en)
ES (1) ES2155802B1 (en)
FR (2) FR2783426A1 (en)
GB (2) GB9920710D0 (en)
ID (1) ID23150A (en)
IL (1) IL131722A0 (en)
IS (1) IS5183A (en)
IT (1) IT1307267B1 (en)
NL (2) NL1013049C2 (en)
NO (1) NO994463L (en)
SE (2) SE9903307L (en)
SG (1) SG76631A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60218299T2 (en) * 2001-04-27 2007-10-31 Ajinomoto Co., Inc. A dispersion of beta-glucan-containing superfine particles, a corresponding manufacturing process and the use of the dispersion
WO2002090559A1 (en) * 2001-05-07 2002-11-14 Biohub Co., Ltd. A method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby
JP4499979B2 (en) * 2001-05-21 2010-07-14 コンビ株式会社 Composition for controlling pathogen infection
JP4561098B2 (en) * 2001-06-01 2010-10-13 味の素株式会社 Diabetes medicine
KR100971599B1 (en) 2002-05-15 2010-07-20 비에이취엔 가부시끼가이샤 Composition for Preventing or Treating Blood Vessel-Related Disease
JP4826696B2 (en) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 Angiogenesis inhibitors
JP4681801B2 (en) * 2002-05-15 2011-05-11 ビーエイチエヌ株式会社 Angiogenesis inhibitor and method for producing the same
JP2005089417A (en) * 2003-09-19 2005-04-07 Noevir Co Ltd Composition for prevention/treatment of diabetes
JP4587441B2 (en) * 2004-02-12 2010-11-24 株式会社クレハ Novel diabetes treatment and food
JP5034071B2 (en) * 2004-09-17 2012-09-26 株式会社Ｓ・Ｓ・Ｉ Kawariharatake extract that suppresses breast cancer
JP2006273835A (en) * 2005-03-04 2006-10-12 Michishi Tani Therapeutic agent for malignant tumor and food or beverage containing the same
US20120128856A1 (en) * 2009-07-31 2012-05-24 Ming East-West, Llc Maitake mushroom coffee
WO2011081024A1 (en) * 2009-12-29 2011-07-07 株式会社富士見養蜂園 Umami food, and method for producing same
CN106309511A (en) * 2016-08-30 2017-01-11 青海民族大学 Effective part of agaricus gennadii for inhibiting CDC25 enzyme as well as preparation method and application of effective part
CN106333969A (en) * 2016-08-30 2017-01-18 青海民族大学 Agaricus gennadii HDAC1 enzyme inhibition effective part and preparation method and application
US20200397817A1 (en) * 2017-11-30 2020-12-24 SHIEH, Darbin Method for predicting and modulating susceptibility of cancer cell to programmed cell death
KR102646421B1 (en) * 2020-12-16 2024-03-12 대한민국 Method for increasing the content of physiologically active ingredients and nutrients in Grifola frondosa
KR102602787B1 (en) * 2020-12-16 2023-11-17 대한민국 Method for increasing the content of physiologically active ingredients and nutrients in Sparassis crispa
KR102584680B1 (en) * 2020-12-17 2023-10-06 대한민국 Method for manufacturing tea of Lentinula edodes tea improved physiological activities and nutrition components

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5276413A (en) * 1975-12-18 1977-06-27 Kureha Chem Ind Co Ltd Production of oncostatic substances
US4177108A (en) * 1977-03-02 1979-12-04 Tetsuro Ikekawa Process for producing emitanin
DE2842691A1 (en) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Activation of pharmaceuticals by irradiation - using wavelengths corresp. to absorption maxima of the substance, opt. with the simultaneous application of magnetic field
JPS57206618A (en) * 1981-06-12 1982-12-18 Noda Shiyokukin Kogyo Kk Preparation of antitumor substance
JPH02203765A (en) * 1989-02-02 1990-08-13 Nippon Beet Sugar Mfg Co Ltd Food having antitumor function and production thereof
JP3357383B2 (en) * 1991-08-14 2002-12-16 昌宏 黒田 Low molecular weight plant composition
JP2955126B2 (en) * 1992-06-22 1999-10-04 笑代 丹羽 Pharmaceutical oleaginous preparation, food oleaginous preparation and production method thereof
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans

Also Published As

Publication number Publication date
ID23150A (en) 2000-03-23
NO994463L (en) 2000-03-20
ES2155802A1 (en) 2001-05-16
IS5183A (en) 2000-03-17
FR2783426A1 (en) 2000-03-24
SE0100195L (en) 2001-01-24
NL1019705C2 (en) 2002-03-26
GB9920710D0 (en) 1999-11-03
JP2000159682A (en) 2000-06-13
BE1012725A5 (en) 2001-02-06
NO994463D0 (en) 1999-09-15
NL1019705A1 (en) 2002-01-29
SE9903307D0 (en) 1999-09-16
SE9903307L (en) 2000-03-18
KR20000023206A (en) 2000-04-25
ITTO990784A0 (en) 1999-09-14
FR2788697A1 (en) 2000-07-28
CN1255376A (en) 2000-06-07
SG76631A1 (en) 2000-11-21
ITTO990784A1 (en) 2001-03-14
GB9921387D0 (en) 1999-11-10
AU4486299A (en) 2000-03-30
GB2341800A (en) 2000-03-29
CA2282234A1 (en) 2000-03-17
DE19944695A1 (en) 2000-03-30
NL1013049C2 (en) 2002-01-11
NL1013049A1 (en) 2000-03-21
IT1307267B1 (en) 2001-10-30
ES2155802B1 (en) 2001-12-01
DK199901235A (en) 2000-03-18
IL131722A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
SE0100195D0 (en) Evaluation procedures for anti-tumor activity
TR199700358A2 (en) �nterferon birle�imler.
BR9916857A (en) 4 heteroaryl diarylamines
PT983286E (en) AMINOALQUIL-GLYCOSAMINE-PHOSPHATE COMPOUNDS AND THEIR USE AS ADJUVANTS EIMUNOEFECTORS
FR2791678B1 (en) 1,4-DIAZABICYCLO [3.2.2] NONANE-4-CARBOXYLATES AND -CARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
NL1003465A1 (en) Implantable transponder and improved formulation method.
PT819122E (en) DERIVATIVES OF 1,3-DIHYDRO-1- (PHENYLALQUIL) -2H-IMIDAZOLE-2-ONA WITH ACTIVITY OF PDE IV AND CYTOKINE
FR2805465B1 (en) NEW PHARMACEUTICAL OR DIETETIC COMPOSITIONS BASED ON MUSHROOMS
FR2809730B1 (en) 1,4-DIAZABICYCLO [3.2.2] NONANEBENZOXAZOLE, -BENZOTHIAZOLE AND -BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
TR199801871A3 (en) Biphenylsulfonylcyanamides production method and their use as drugs.
IT1293910B1 (en) ARMREST OF CHAIR, AND CHAIR USING SUCH ARMREST.
ITRE990028A0 (en) CHELATED FOOD SUPPLEMENT FOR AGRO-ZOOTECHNICAL USE, AND METHOD FOR OBTAINING THE SAME.
DE60006448D1 (en) Mercapto alcohol compounds than as flavorings
IT9022341A0 (en) EXTRACTS FROM ANIMAL TISSUES, USEFUL IN THERAPY AND DIAGNOSTICS.
FR2756563B1 (en) 1,4-DIAZABICYCLO [2.2.2] OCT-2-YL-METHYL BENZOATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
ATE252096T1 (en) PROLYLENDOPEPTIDASE INHIBITORS, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE
FR2845388B1 (en) 1,4-DIAZABICYCLO [3.2.2] NONANECARBOXAMIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FI965064A0 (en) Water-soluble high molecular weight compound containing silicone and its production and use
FR2779429B1 (en) OXINDOLE DERIVATIVES, THEIR PREPARATIONS AND THEIR THERAPEUTIC APPLICATIONS
ATE305455T1 (en) 1,3-DIHYDRO-2H-IMIDAZOLE-2-ONE DERIVATIVES WITH PDEIV AND CYTOKINE INHIBITING ACTIVITY
DE69610948D1 (en) IMMUNOENZYMATIC CONJUGATE, PRODUCTION METHOD THEREFOR AND USES
EP0836480A4 (en) Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof
IL138117A0 (en) 5-imino-13-deoxy anthracycline derivatives, their uses and processes for preparing them
DE69613793D1 (en) Ophthalmic Cromolyn gel preparation
WO2003060467A3 (en) Method for analyzing effects of medical agents

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 0100195-7

Format of ref document f/p: F